- ¥1tn
- ¥903bn
- ¥496bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.96 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -5.14% | ||
| Dividend Yield (f) | 2.78% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.35 | ||
| Price to Tang. Book | 2.28 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.32 | ||
| EV to EBITDA | 8.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.21% | ||
| Return on Equity | 7.1% | ||
| Operating Margin | 16.78% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 318,352 | 352,246 | 398,371 | 442,233 | 495,558 | 479,940 | 502,550 | 10.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +12 | +4.4 | +22.26 | +19.09 | -17.05 | -14.33 | +17.89 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kyowa Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of medical drugs. The Company operates in Pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has drug discovery technologies in antibody therapeutics and hematopoietic stem cell gene therapy. Its development pipeline includes AMG531 for aplastic anemia untreated with immunosuppressive therapy, KHK4083/AMG 451 for moderate to severe atopic dermatitis, KHK4083/AMG 451 for moderate to severe asthma, and KK2845 for acute myeloid leukemia and others. In addition, through its subsidiaries, the Company develops, manufactures, markets, and contracts out biosimilar pharmaceuticals, and engages in wholesale and retail sales and insurance agency business. The Company operates in Japan and overseas.
Directors
- Masashi Miyamoto PRE (61)
- Motohiko Kawaguchi FID
- Toshifumi Mikayama VPR (63)
- Yutaka Ohsawa VPR (61)
- Wataru Murata SME
- Kenya Shitara MEO
- Takeyoshi Yamashita MEO
- Hiroshi Sonekawa DSL
- Yasuo Fujii EXO
- Shin Inoue EXO
- Koichiro Ishimaru EXO
- Shoko Itagaki EXO
- Jean Kabe EXO
- Fumihiko Kanai EXO
- Toshiyuki Kurata EXO
- Mitsuo Sato EXO
- Kenji Shibata EXO
- Tomohiro Sudo EXO
- Hiroki Takamatsu EXO
- Yoshifumi Torii EXO
- Nobuyuki Tsukahara EXO
- Noriya Yokota DRC (60)
- Jun Arai IND (62)
- Yuko Haga IND (65)
- Akira Morita IND (69)
- Kentaro Uryu IND (57)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 1st, 1949
- Public Since
- August 22nd, 1949
- No. of Shareholders
- 33,087
- No. of Employees
- 5,669
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 523,357,776
- Address
- Otemachi Financial City Grand Cube, CHIYODA-KU, 100-0004
- Web
- https://www.kyowakirin.co.jp/
- Phone
- +81 352057200
- Auditors
- KPMG AZSA LLC
Upcoming Events for 4151
Dividend For 4151.T - 30.0000 JPY
Q2 2025 Kyowa Kirin Co Ltd Earnings Release
Similar to 4151
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Kyowa Kirin Co share price?
As of Today at 21:41 UTC, shares in Kyowa Kirin Co are trading at ¥2,199. This share price information is delayed by 15 minutes.
How has the Kyowa Kirin Co share price performed this year?
Shares in Kyowa Kirin Co last closed at ¥2,199 and the price had moved by -16.2% over the past 365 days. In terms of relative price strength the Kyowa Kirin Co share price has underperformed the Nikkei 225 Index by -11.68% over the past year.
What are the analyst and broker recommendations for Kyowa Kirin Co?
The overall consensus recommendation for Kyowa Kirin Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Kyowa Kirin Co dividend yield?
The Kyowa Kirin Co dividend yield is 2.64% based on the trailing twelve month period.
Does Kyowa Kirin Co pay a dividend?
Last year, Kyowa Kirin Co paid a total dividend of ¥58, and it currently has a trailing dividend yield of 2.64%.Looking ahead, shares in Kyowa Kirin Co are due to go ex-dividend on 2025-06-27 and the next dividend pay date is 2025-09-01.
When does Kyowa Kirin Co next pay dividends?
Kyowa Kirin Co are due to go ex-dividend on 2025-06-27 and the next dividend pay date is 2025-09-01. The historic dividend yield on Kyowa Kirin Co shares is currently 2.64%.
How do I buy Kyowa Kirin Co shares?
To buy shares in Kyowa Kirin Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kyowa Kirin Co?
As of the previous close price of ¥2,199, shares in Kyowa Kirin Co had a market capitalisation of ¥1tn.
Where are Kyowa Kirin Co shares listed?
Here are the trading details for Kyowa Kirin Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4151
What kind of share is Kyowa Kirin Co?
Based on an overall assessment of its quality, value and momentum Kyowa Kirin Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kyowa Kirin Co share price forecast for 2025?
The analyst consensus target price for shares in Kyowa Kirin Co is ¥2,726. That is 23.96% above the last closing price of ¥2,199.
Analysts covering Kyowa Kirin Co currently have a consensus Earnings Per Share (EPS) forecast of ¥110 for the next financial year.
Find out moreWhat is the trend in the Kyowa Kirin Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kyowa Kirin Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -6.12%.
As of the last closing price of ¥2,199, shares in Kyowa Kirin Co were trading -14.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kyowa Kirin Co PE Ratio?
The Kyowa Kirin Co PE ratio based on its reported earnings over the past 12 months is 18.96. The shares last closed at ¥2,199.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kyowa Kirin Co?
Kyowa Kirin Co's management team is headed by:
- Masashi Miyamoto - PRE
- Motohiko Kawaguchi - FID
- Toshifumi Mikayama - VPR
- Yutaka Ohsawa - VPR
- Wataru Murata - SME
- Kenya Shitara - MEO
- Takeyoshi Yamashita - MEO
- Hiroshi Sonekawa - DSL
- Yasuo Fujii - EXO
- Shin Inoue - EXO
- Koichiro Ishimaru - EXO
- Shoko Itagaki - EXO
- Jean Kabe - EXO
- Fumihiko Kanai - EXO
- Toshiyuki Kurata - EXO
- Mitsuo Sato - EXO
- Kenji Shibata - EXO
- Tomohiro Sudo - EXO
- Hiroki Takamatsu - EXO
- Yoshifumi Torii - EXO
- Nobuyuki Tsukahara - EXO
- Noriya Yokota - DRC
- Jun Arai - IND
- Yuko Haga - IND
- Akira Morita - IND
- Kentaro Uryu - IND